14 APIs/26 Products Including Third Domestic Biosimilar Receive Listing

June 3, 2013
The Ministry of Health, Labor and Welfare (MHLW) announced the listing of 14 active pharmaceutical ingredients (APIs)/26 report products and new kit products including a biosimilar of the recombinant human granulocyte colony stimulating factor (G-CSF) filgrastim (original product: Kyowa Hakko...read more